World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
92
Citations
35736
World Ranking
2192
National Ranking
1183

Research.com Recognitions

  • 1991 - US President's National Medal of Science "For his contribution to hematology in defining the genetic basis for G6PD deficiency and thalassemia, and discovery of an approach to control cancer cell proliferation with new inducers of differentiation.", Presented by President Bush at a White House Rose Garden Ceremony on September 16, 1991.
  • 1982 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1973 - Member of the National Academy of Sciences

Overview

Paul A. Marks was affiliated with Columbia University in the United States. Their research spanned several interrelated scientific fields, primarily focusing on Medicine, Biochemistry, Genetics and Molecular Biology, and Engineering. The work contributed to both foundational and applied aspects of biomedical sciences and related technologies.

Their publications addressed a range of topics within the biomedical research landscape. Key areas of focus included:

  • Fibroblast Growth Factor Research
  • Tissue Engineering and Regenerative Medicine
  • Connective Tissue Disorders Research
  • 3D Printing in Biomedical Research
  • Osteoarthritis Treatment and Mechanisms
  • Bone Tissue Engineering Materials
  • Medical Imaging and Pathology Studies

Major subfields in their work included Biomedical Engineering, Molecular Biology, Surgery, Genetics, and Rheumatology.

Their scholarly output included papers published in venues such as bioRxiv (Cold Spring Harbor Laboratory) and the SSRN Electronic Journal. Notable recent publications were:

  • "FGF9 treatment reduces off-target chondrocytes from iPSC-derived kidney organoids" (2024), bioRxiv (Cold Spring Harbor Laboratory)
  • "Packed for Ossification: High-Density Bioprinting of hPDC Spheroids in HAMA for Endochondral Ossification" (2025), bioRxiv (Cold Spring Harbor Laboratory)
  • "Packed for Ossification: High-Density Bioprinting of hPDC Spheroids in HAMA for Endochondral Ossification" (2025), SSRN Electronic Journal

Frequent coauthors included Ane Albillos Sanchez, Paula Casademunt, Adrián Seijas-Gamardo, Lorenzo Moroni, and Carlos Mota, each collaborating on multiple publications.

Throughout their career, Paul A. Marks received several recognitions including being named a Member of the National Academy of Sciences (1973) and a Fellow of the American Association for the Advancement of Science (AAAS) in 1982. In 1991, they were awarded the US President's National Medal of Science for contributions to hematology, specifically for defining the genetic basis for G6PD deficiency and thalassemia and for discovering an approach to control cancer cell proliferation with new inducers of differentiation.

Best Publications

  • Histone deacetylases and cancer: causes and therapies.

    Paul A. Marks;Richard A. Rifkind;Victoria M. Richon;Ronald Breslow

  • Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.

    Michael S. Finnin;Jill R. Donigian;Alona Cohen;Victoria M. Richon

  • A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases

    Victoria M. Richon;Stephane Emiliani;Eric Verdin;Yael Webb

  • Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

    E. Hockly;V.M. Richon;B. Woodman;D.L. Smith

  • Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications

    Constantine S. Mitsiades;Nicholas S. Mitsiades;Ciaran J. McMullan;Vassiliki Poulaki

  • The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin

    Lisa M. Butler;Xianbo Zhou;Wei-Sheng Xu;Howard I. Scher

  • Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors

    Melissa J. Peart;Gordon K. Smyth;Ryan K. van Laar;David D. Bowtell

  • Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

    V M Richon;Y Webb;R Merger;T Sheppard

  • A new group of potent inducers of differentiation in murine erythroleukemia cells.

    Roberta C. Reuben;Richard L. Wife;Ronald Breslow;Richard A. Rifkind

  • The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.

    Pamela N. Munster;Tiffany Troso-Sandoval;Neal Rosen;Richard Rifkind

  • Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.

    Li-Zhen He;Thomas Tolentino;Peter Grayson;Sue Zhong

  • Molecular sequelae of histone deacetylase inhibition in human malignant B cells

    Nicholas Mitsiades;Constantine S. Mitsiades;Paul G. Richardson;Ciaran McMullan

  • Cloning and characterization of a histone deacetylase, HDAC9

    Xianbo Zhou;Paul A. Marks;Richard A. Rifkind;Victoria M. Richon

  • Lipid synthesis in human leukocytes, platelets, and erythrocytes.

    Paul A. Marks;Alfred Gellhorn;Chev Kidson

  • Novel potent inducers of terminal differentiation and methods of use thereof

    Ronald Breslow;Paul A. Marks;Richard A. Rifkind;Branko Jursic

  • Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture

    H Yamasaki;E Fibach;U Nudel;I B Weinstein

  • Induction of erythroid differentiation in murine virus infected eythroleukemia cells by highly polar compounds.

    Masao Tanaka;Joseph Levy;Masaaki Terada;Ronald Breslow

  • INHIBITION OF MAMMALIAN GLUCOSE-6-PHOSPHATE DEHYDROGENASE BY STEROIDS.

    Paul A. Marks;Julia Banks

  • Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents

    Mandana Namdar;Gisela Perez;Lang Ngo;Paul A. Marks

  • Effect of Hexamethylene Bisacetamide on the Commitment to Differentiation of Murine Erythroleukemia Cells

    Eitan Fibach;Roberta C. Reuben;Richard A. Rifkind;Paul A. Marks

Frequent Co-Authors

Richard A. Rifkind
Richard A. Rifkind Memorial Sloan Kettering Cancer Center
Arthur Bank
Arthur Bank Columbia University
Ronald Breslow
Ronald Breslow Columbia University
Masaaki Terada
Masaaki Terada National Cancer Research Institute, UK
Uri Nudel
Uri Nudel Weizmann Institute of Science
Roberto Gambari
Roberto Gambari University of Ferrara
Francesco Ramirez
Francesco Ramirez Icahn School of Medicine at Mount Sinai
Lisa M. Butler
Lisa M. Butler University of Adelaide
Jane E. Salmon
Jane E. Salmon Hospital for Special Surgery

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Paul A. Marks